Malaria Vaccine (R21/Matrix-M)
Travel Vaccine · 5–36 months (children in endemic areas)
5–36 months (children in endemic areas)
Age Group
75–80% efficacy in seasonal malaria prevention
Efficacy
Pricing being established for endemic countries
Cost Range
Serum Institute of India (R21/Matrix-M)
Manufacturer
💉About the Malaria Vaccine (R21/Matrix-M) Vaccine
R21/Matrix-M is a malaria vaccine developed by the University of Oxford and Serum Institute of India. WHO recommended RTS,S in 2021; R21 shows higher efficacy. First vaccine to significantly reduce malaria in children.
More About the Malaria Vaccine (R21/Matrix-M) Vaccine
Sponsored
Book a Vaccination
Stay protected with expert care
Why Lab Dekho?
- ✅WHO-recognised vaccination centres
- 🏠Home vaccination in 100+ cities
- 📋Digital vaccination certificates
- 🔔Dose reminders & schedule tracking
- 📞24/7 medical helpline support
Book Your Vaccination
Find certified travel vaccine centres
Quick Cost Estimate
Malaria Vaccine (R21/Matrix-M) Available Now
Book a slot · Home visit available
Sponsored
Book a Vaccination
Stay protected with expert care
⚕️ Medical Disclaimer
This page is for informational purposes only and does not substitute professional medical advice. Always consult a qualified healthcare professional before vaccination. In emergencies, call 112.